Sandoz Group (OTCMKTS:SDZNY) Shares Gap Up – Still a Buy?
by Michael Walen · The Markets DailyShares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up prior to trading on Thursday. The stock had previously closed at $85.87, but opened at $89.99. Sandoz Group shares last traded at $90.03, with a volume of 857 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Erste Group Bank upgraded Sandoz Group to a “strong-buy” rating in a research note on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Strong Buy”.
Check Out Our Latest Stock Report on Sandoz Group
Sandoz Group Stock Performance
The business’s 50-day simple moving average is $86.12 and its 200-day simple moving average is $84.14.
About Sandoz Group
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on developing, manufacturing and marketing generic and biosimilar medicines. Its portfolio is designed to expand access to established treatments by offering alternatives to branded products after patent or regulatory exclusivity periods end.
The company supplies medicines across a range of therapeutic areas, including anti-infectives, ophthalmology, respiratory care, central nervous system treatments, dermatology, transplantation and immunology.
Featured Articles
- Five stocks we like better than Sandoz Group
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation